JPY 1579.0
(3.88%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 4.39 Billion JPY | 15.35% |
2022 | 3.79 Billion JPY | -10.56% |
2021 | 4.47 Billion JPY | 121.96% |
2020 | 2.3 Billion JPY | 116.07% |
2019 | -23.48 Billion JPY | -234.96% |
2018 | 7.95 Billion JPY | 44.88% |
2017 | 6.57 Billion JPY | 77.71% |
2016 | 3.84 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q3 | 129 Million JPY | -91.46% |
2024 Q1 | 1.5 Billion JPY | -20.37% |
2024 Q2 | 1.09 Billion JPY | 46.89% |
2023 Q3 | 612 Million JPY | -48.09% |
2023 FY | - JPY | 15.35% |
2023 Q4 | 1.29 Billion JPY | 110.95% |
2023 Q2 | 1.17 Billion JPY | 7.57% |
2023 Q1 | 1.09 Billion JPY | -19.88% |
2022 FY | - JPY | -10.56% |
2022 Q3 | -110 Million JPY | -136.07% |
2022 Q2 | 305 Million JPY | -86.12% |
2022 Q1 | 2.19 Billion JPY | 1415.17% |
2022 Q4 | 1.36 Billion JPY | 1343.64% |
2021 Q1 | 1.43 Billion JPY | -39.17% |
2021 Q4 | 145 Million JPY | -79.58% |
2021 Q3 | 710 Million JPY | -63.51% |
2021 Q2 | 1.94 Billion JPY | 35.89% |
2021 FY | - JPY | 121.96% |
2020 FY | - JPY | 116.07% |
2020 Q4 | 2.35 Billion JPY | 89.38% |
2020 Q3 | 1.24 Billion JPY | 257.94% |
2020 Q2 | -787 Million JPY | -1810.87% |
2020 Q1 | 46 Million JPY | 100.63% |
2019 Q1 | 1.29 Billion JPY | -13.11% |
2019 Q4 | -7.29 Billion JPY | -142.86% |
2019 Q3 | -3 Billion JPY | 47.44% |
2019 Q2 | -5.71 Billion JPY | -540.11% |
2019 FY | - JPY | -234.96% |
2018 Q3 | 1.73 Billion JPY | 908.14% |
2018 Q2 | 172 Million JPY | 0.0% |
2018 FY | - JPY | 44.88% |
2018 Q4 | 1.49 Billion JPY | -13.78% |
2018 Q1 | 172 Million JPY | 0.0% |
2017 FY | - JPY | 77.71% |
2016 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Kitanotatsujin Corporation | 1.58 Billion JPY | -176.716% |
Euglena Co., Ltd. | 676 Million JPY | -550.0% |
BEAUTY GARAGE Inc. | 1.96 Billion JPY | -123.633% |
Axas Holdings Co.,Ltd. | 555.75 Million JPY | -690.632% |
C.I. Medical Co.,Ltd. | 4.01 Billion JPY | -9.494% |
Kao Corporation | 154.49 Billion JPY | 97.156% |
Niitaka Co., Ltd. | 1.36 Billion JPY | -220.842% |
Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 91.006% |
Shiseido Company, Limited | 106.46 Billion JPY | 95.873% |
Lion Corporation | 42.31 Billion JPY | 89.616% |
Mandom Corporation | 6.69 Billion JPY | 34.408% |
Ivy Cosmetics Corporation | 242.6 Million JPY | -1711.212% |
Milbon Co., Ltd. | 7.8 Billion JPY | 43.67% |
Nippon Shikizai, Inc. | 1.28 Billion JPY | -240.997% |
Fancl Corporation | 16.6 Billion JPY | 73.535% |
KOSÉ Corporation | 26.85 Billion JPY | 83.639% |
Cota Co., Ltd. | 2.26 Billion JPY | -93.699% |
HABA Laboratories,Inc. | -1.31 Billion JPY | 434.32% |
C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | -2456.926% |
Pola Orbis Holdings Inc. | 23.17 Billion JPY | 81.042% |
Noevir Holdings Co., Ltd. | 12.24 Billion JPY | 64.113% |
Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -3443.548% |
Almado, Inc. | 983.21 Million JPY | -346.9% |
I-ne CO., LTD. | 4.7 Billion JPY | 6.511% |
Premier Anti-Aging Co., Ltd. | -627 Million JPY | 800.797% |
Liberta Co.,Ltd. | 318.19 Million JPY | -1280.927% |
AXXZIA Inc. | 1.28 Billion JPY | -241.545% |
S.T. Corporation | 2.62 Billion JPY | -67.327% |
Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | 86.132% |
Earth Corporation | 10.6 Billion JPY | 58.578% |
Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | -301.445% |
Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 865.531% |
Ya-Man Ltd. | 1.43 Billion JPY | -205.825% |
TRANSACTION CO.,Ltd. | 5.8 Billion JPY | 24.362% |
SHOBIDO Corporation | 1.11 Billion JPY | -295.786% |
Artnature Inc. | 3.78 Billion JPY | -16.029% |
Pigeon Corporation | 15.8 Billion JPY | 72.2% |
Unicharm Corporation | 178.01 Billion JPY | 97.532% |
Paltac Corporation | 35.92 Billion JPY | 87.768% |
CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | -33.76% |